Kairos Pharma宣布进行1比7反向股票拆分以维持纽约证券交易所合规

2026-08-22 04:38

Kairos Pharma (KAPA) announced on Friday that it will conduct a 1-for-7 reverse stock split effective September 1, 2026, before the market opens.
The company’s shares will continue trading on the NYSE American under the ticker KAPA.
Under the split, every 7 shares will be combined into 1 share, with fractional shares rounded up to the nearest whole share.
The reverse split will proportionately adjust the company’s convertible notes, warrants, and equity awards.
The company said the move is intended to increase its per-share trading price and help maintain compliance with NYSE American listing requirements.
On the market side, the shares traded over 7% lower at ~$0.27 in the after-hours trading session.

More on Kairos Pharma, Ltd.